Clinical Research Directory
Browse clinical research sites, groups, and studies.
Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Sponsor: Centre Hospitalier de PAU
Summary
The HAMA bank is an initiative aimed at collecting, preparing, and storing biological samples from patients treated for malignant hypertension and included in the HAMA cohort. Conducted under CRB (ISO20387) conditions, this biobank serves as an essential resource for understanding the disease's pathophysiology, as well as for identifying novel biomarkers and therapeutic targets
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-08-01
Completion Date
2036-04-01
Last Updated
2025-07-30
Healthy Volunteers
No
Conditions
Interventions
biobank
The following samples will be collected : * Serum samples and plasma sample: inclusion visit and follow up visit * Urines samples : inclusion visit and follow up visit * blood DNA: inclusion visit * Blood RNA: inclusion visit and follow up visit